Morgan Stanley’s Picard Medical PMI Stock Holding History
Bought
Maintained
Sold
Other funds holding PMI
IC
Morgan Stanley's PMI Position: Q2 2026 in Review
Morgan Stanley reduced its Picard Medical (PMI) stake by 74% in Q2 2026, selling an estimated $2.02K and leaving 33 shares worth $271. The position accounts for ﹤0.01% of the portfolio, ranked #7800.
Morgan Stanley first reported a position in PMI in Q3 2025 and has held it in 4 quarters since. The position peaked at $43K in Q3 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q2 2026.
- Morgan Stanley held 33 shares of Picard Medical worth $271 as of Q2 2026.
- Morgan Stanley sold 95 Picard Medical shares in Q2 2026, an estimated $2.02K.
- Picard Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7800 holding.
- Morgan Stanley first reported a position in Picard Medical in Q3 2025 and has held it in 4 quarters since.
- Morgan Stanley's Picard Medical position peaked at $43K in Q3 2025.
- 41 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.